Figure 7.
miR-98-5p inhibits tumor growth in vivo. (A) Representative images of tumors after different treatments at day 21. (B) Inhibition of tumor growth in the subcutaneous xenograft tumor model of A549 cells after the different treatments. (C) Weight of tumors after different treatments at day 21. (D) H&E evaluation and immunohistochemistry analysis of Ki-67, MMP-9 and TGFBR1 in tumor sections after different treatments. Magnification, ×200. TGFBR1, transforming growth factor beta receptor 1. **P<0.01 vs. control.